WO2009007412A3 - Deglycation des ages - Google Patents

Deglycation des ages Download PDF

Info

Publication number
WO2009007412A3
WO2009007412A3 PCT/EP2008/058955 EP2008058955W WO2009007412A3 WO 2009007412 A3 WO2009007412 A3 WO 2009007412A3 EP 2008058955 W EP2008058955 W EP 2008058955W WO 2009007412 A3 WO2009007412 A3 WO 2009007412A3
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
deglycation
age
substance
preventing
Prior art date
Application number
PCT/EP2008/058955
Other languages
English (en)
Other versions
WO2009007412A2 (fr
Inventor
Nabil Abdul-Malak
Cecile Altobelli
Eric Perrier
Original Assignee
Basf Beauty Care Solutions F
Nabil Abdul-Malak
Cecile Altobelli
Eric Perrier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Beauty Care Solutions F, Nabil Abdul-Malak, Cecile Altobelli, Eric Perrier filed Critical Basf Beauty Care Solutions F
Priority to US12/668,061 priority Critical patent/US20100203175A1/en
Priority to CN200880101123A priority patent/CN101765432A/zh
Priority to JP2010515508A priority patent/JP2010533143A/ja
Priority to BRPI0813925-3A2A priority patent/BRPI0813925A2/pt
Priority to EP08786013A priority patent/EP2170358A2/fr
Publication of WO2009007412A2 publication Critical patent/WO2009007412A2/fr
Publication of WO2009007412A3 publication Critical patent/WO2009007412A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/415—Aminophenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)

Abstract

L'invention concerne l'utilisation comme ingrédient actif d'au moins une substance favorisant la déglycation des AGEs pour la préparation d'une composition, notamment pour limiter la présence des AGEs au niveau d'un tissu. L'invention concerne en particulier l'utilisation d'une telle substance pour la préparation d'une composition destinée à prévenir et/ou lutter contre la diminution de la flexibilité, et/ou de la plasticité, et/ou de l'élasticité, et/ou de la fonctionnalité d'un tissu, et/ou à prévenir et/ou lutter contre le vieillissement d'un tissu, en favorisant la déglycation des AGEs au niveau du tissu, ledit tissu étant de préférence la peau, ou la paroi tissulaire d'un vaisseau sanguin ou d'un organe.
PCT/EP2008/058955 2007-07-09 2008-07-09 Deglycation des ages WO2009007412A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12/668,061 US20100203175A1 (en) 2007-07-09 2008-07-09 DEGLYCATION OF AGEs
CN200880101123A CN101765432A (zh) 2007-07-09 2008-07-09 Age的去糖化
JP2010515508A JP2010533143A (ja) 2007-07-09 2008-07-09 Ａｇｅの脱糖化
BRPI0813925-3A2A BRPI0813925A2 (pt) 2007-07-09 2008-07-09 Utilização de pelo menos uma substância favorecendo a reversão da reação de maillard frente aos ages, método de triagem de princípios ativos favorecendo a deglicação dos ages e composição.
EP08786013A EP2170358A2 (fr) 2007-07-09 2008-07-09 Deglycation des ages.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756350 2007-07-09
FR0756350A FR2918570B1 (fr) 2007-07-09 2007-07-09 DIGLYCATION DES AGEs.

Publications (2)

Publication Number Publication Date
WO2009007412A2 WO2009007412A2 (fr) 2009-01-15
WO2009007412A3 true WO2009007412A3 (fr) 2009-04-02

Family

ID=39262794

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/058955 WO2009007412A2 (fr) 2007-07-09 2008-07-09 Deglycation des ages

Country Status (8)

Country Link
US (1) US20100203175A1 (fr)
EP (1) EP2170358A2 (fr)
JP (2) JP2010533143A (fr)
KR (1) KR20100047253A (fr)
CN (2) CN101765432A (fr)
BR (1) BRPI0813925A2 (fr)
FR (2) FR2918570B1 (fr)
WO (1) WO2009007412A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928548B1 (fr) * 2008-03-14 2015-07-03 Basf Beauty Care Solutions F Substances augmentant le seuil d'activation des cellules immunes
JP2010077123A (ja) * 2008-08-29 2010-04-08 Hayashikane Sangyo Kk メイラード反応阻害剤
FR2951085B1 (fr) * 2009-10-09 2012-05-18 Inst Substances Vegetales Utilisation de composes phenoliques pour la deglycation des proteines
FR2954702B1 (fr) 2009-12-31 2013-07-05 Basf Beauty Care Solutions F Agent stimulant l'expression de loxl
CN102883733B (zh) * 2010-02-10 2014-08-13 奥力榨油化株式会社 Age生成抑制剂
JP6012138B2 (ja) * 2010-10-04 2016-10-25 小林製薬株式会社 抗糖化剤
JP5855492B2 (ja) * 2012-02-27 2016-02-09 三省製薬株式会社 ＡＧＥｓ産生抑制剤
JP6054700B2 (ja) * 2012-10-10 2016-12-27 株式会社ノエビア 脱糖化剤及び皮膚外用剤
JP2015096488A (ja) * 2013-10-10 2015-05-21 康二 嘉島 終末糖化物質生成抑制方法
CN105770357A (zh) * 2015-10-16 2016-07-20 北京冠瑞金生物科技有限公司 蒜氨酸在制备抗抑郁症药物中的用途
JP2017088538A (ja) * 2015-11-10 2017-05-25 日本メナード化粧品株式会社 フィラグリン産生促進剤
KR102605628B1 (ko) * 2015-12-29 2023-11-22 주식회사 엘지생활건강 하스타토사이드를 포함하는 피부상태 개선용 조성물
CN114788791A (zh) 2017-06-23 2022-07-26 宝洁公司 用于改善皮肤外观的组合物和方法
JP2019214546A (ja) * 2018-06-11 2019-12-19 学校法人福岡大学 終末糖化産物生成抑制剤及び医薬組成物
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
CN109468370A (zh) * 2018-11-09 2019-03-15 广州益养生物科技有限公司 一种快速检测遗传性皮肤糖基化能力基因的方法
CN110684212A (zh) * 2019-10-31 2020-01-14 东南大学 一种仿贻贝的水下高粘性水凝胶的制备方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (fr) 2020-06-01 2023-04-05 The Procter & Gamble Company Méthode d'amélioration de la pénétration d'un composé de vitamine b3 dans la peau
CN112111020B (zh) * 2020-10-26 2022-07-19 无锡善元健康管理有限公司 桦树茸中抗糖成分的提取纯化及抗糖丸的制备方法
CN112370370B (zh) * 2020-11-19 2022-07-26 苏州禾研生物技术有限公司 一种氧糖双抗的组合物及其应用和氧糖双抗的产品
CN113876668B (zh) * 2021-11-16 2023-11-03 上海青颜博识生物技术有限公司 一种抗糖化植物来源组合物及其制备方法和在美容产品中的应用

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0238302A1 (fr) * 1986-03-17 1987-09-23 Richardson-Vicks, Inc. Composition de traitement de la peau
WO1993010756A1 (fr) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Emploi d'acide salicylique contre les rides et/ou l'atrophie cutanee
JPH0977655A (ja) * 1995-09-14 1997-03-25 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
WO2000027395A1 (fr) * 1998-11-10 2000-05-18 Alteon, Inc. Inversion des liaisons croisees de glycosylation avancee a l'aide de sels de thiazolium a substitution heterocyclique
FR2787324A1 (fr) * 1998-12-21 2000-06-23 Serobiologiques Lab Sa Utilisation d'au moins un extrait d'une plante appartenant au genre cecropia et composition cosmetique ou dermopharmaceutique comportant un tel extrait
EP1145709A1 (fr) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Utilisation de produits naturels pour préparer des compositions cosmétiques
WO2001076584A2 (fr) * 2000-04-05 2001-10-18 City Of Hope Nouveaux composes permettant de rompre des produits finaux de glycation avancee
WO2002076443A1 (fr) * 2001-03-08 2002-10-03 City Of Hope Nouveaux agents de rupture de produits terminaux de glycation avancee
US20030072820A1 (en) * 1997-06-06 2003-04-17 Laboratoires Serobiologiques (Societe Anonyme) Cosmetic containing plant extracts
EP1304101A1 (fr) * 2001-10-19 2003-04-23 Torrent Pharmaceuticals Ltd Composition comprenant des dérivés de pyridine et leurs utilisations cosmétique et thérapeutique
JP2005029556A (ja) * 2002-10-31 2005-02-03 Ikeda Shokken Kk 皮膚老化防止剤
JP2007119373A (ja) * 2005-10-26 2007-05-17 Arkray Inc メイラード反応生成物分解剤およびそれを用いた飲食品

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2552297B2 (ja) * 1987-07-03 1996-11-06 ポーラ化成工業株式会社 美肌化粧料
FR2653336B1 (fr) * 1989-10-20 1994-04-08 Oreal Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
JP3625501B2 (ja) * 1994-10-06 2005-03-02 御木本製薬株式会社 細胞賦活用皮膚外用剤原料の製造方法及び細胞賦活用皮膚外用剤
JPH08133940A (ja) * 1994-11-02 1996-05-28 Pola Chem Ind Inc 紫外線吸収剤及びこれを含有する化粧料
JP2000256259A (ja) * 1999-03-11 2000-09-19 Nippon Zoki Pharmaceut Co Ltd メイラード反応阻害剤
ATE260099T1 (de) * 1999-04-05 2004-03-15 Hope City Neue hemmern von fortgeschrittenen glykosilierung-endprodukten
FR2813195B1 (fr) * 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
ES2231685T3 (es) * 2001-04-05 2005-05-16 Torrent Pharmaceuticals Ltd Compuestos heterociclicos para complicaciones vasculares diabeticas y relacionadas con la edad.
WO2003032969A2 (fr) * 2001-10-15 2003-04-24 National Research Council Of Canada Agents anti-glycation destines a la prevention des complications liees a l'age, au diabete et au tabagisme
KR20040038243A (ko) * 2002-10-31 2004-05-08 (주)마이코스메틱 생열귀나무 추출물을 함유하는 항산화 또는 항노화용 피부화장료 조성물
EP1437117A1 (fr) * 2002-12-19 2004-07-14 Cognis France S.A. Utilisation d'acide sinapique ou/et de ses dérivés
JP5044122B2 (ja) * 2003-10-24 2012-10-10 株式会社明治 後期糖化最終生成物形成の新規阻害剤及びアルドース還元酵素阻害剤
US20050137239A1 (en) * 2003-12-17 2005-06-23 Hines Michelle D. Thiazole derivatives
US20070098824A1 (en) * 2005-10-27 2007-05-03 Kgk Synergize Inc. Canola extracts containing high levels of phenolic acids
WO2008073684A1 (fr) * 2006-12-08 2008-06-19 Lipo Chemicals Inc. Composition pour traiter le vieillissement de la peau comprenant un acide hydroxycinnamique tel que l'acide p-coumarique

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0238302A1 (fr) * 1986-03-17 1987-09-23 Richardson-Vicks, Inc. Composition de traitement de la peau
WO1993010756A1 (fr) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Emploi d'acide salicylique contre les rides et/ou l'atrophie cutanee
JPH0977655A (ja) * 1995-09-14 1997-03-25 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
US20030072820A1 (en) * 1997-06-06 2003-04-17 Laboratoires Serobiologiques (Societe Anonyme) Cosmetic containing plant extracts
WO2000027395A1 (fr) * 1998-11-10 2000-05-18 Alteon, Inc. Inversion des liaisons croisees de glycosylation avancee a l'aide de sels de thiazolium a substitution heterocyclique
FR2787324A1 (fr) * 1998-12-21 2000-06-23 Serobiologiques Lab Sa Utilisation d'au moins un extrait d'une plante appartenant au genre cecropia et composition cosmetique ou dermopharmaceutique comportant un tel extrait
WO2001076584A2 (fr) * 2000-04-05 2001-10-18 City Of Hope Nouveaux composes permettant de rompre des produits finaux de glycation avancee
EP1145709A1 (fr) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Utilisation de produits naturels pour préparer des compositions cosmétiques
WO2002076443A1 (fr) * 2001-03-08 2002-10-03 City Of Hope Nouveaux agents de rupture de produits terminaux de glycation avancee
EP1304101A1 (fr) * 2001-10-19 2003-04-23 Torrent Pharmaceuticals Ltd Composition comprenant des dérivés de pyridine et leurs utilisations cosmétique et thérapeutique
JP2005029556A (ja) * 2002-10-31 2005-02-03 Ikeda Shokken Kk 皮膚老化防止剤
JP2007119373A (ja) * 2005-10-26 2007-05-17 Arkray Inc メイラード反応生成物分解剤およびそれを用いた飲食品

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200514, Derwent World Patents Index; AN 2005-127358, XP002499539 *
SZWERGOLD ET AL: "Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 336, no. 1, 14 October 2005 (2005-10-14), pages 36 - 41, XP005015282, ISSN: 0006-291X *

Also Published As

Publication number Publication date
WO2009007412A2 (fr) 2009-01-15
CN103816095A (zh) 2014-05-28
FR2975495B1 (fr) 2017-06-09
KR20100047253A (ko) 2010-05-07
US20100203175A1 (en) 2010-08-12
JP2010533143A (ja) 2010-10-21
CN101765432A (zh) 2010-06-30
FR2918570B1 (fr) 2012-10-05
EP2170358A2 (fr) 2010-04-07
FR2918570A1 (fr) 2009-01-16
FR2975495A1 (fr) 2012-11-23
BRPI0813925A2 (pt) 2014-12-30
JP2014028814A (ja) 2014-02-13

Similar Documents

Publication Publication Date Title
WO2009007412A3 (fr) Deglycation des ages
BRPI0923589A2 (pt) uso de uma composição espumável essencialmente livre de ingredientes farmaceuticamente ativos para o tratamento da pele humana.
WO2011061330A3 (fr) Utilisation d'agents rafraîchissants physiologiques et produits contenant de tels agents
CL2013001436A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
WO2012087742A3 (fr) Procédés et compositions appropriés pour la gestion de la glycémie chez des animaux
WO2012051318A8 (fr) Composés sulfonamides et leurs procédés de fabrication et d'utilisation
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
WO2007030666A3 (fr) Preparation medicamenteuse de soin de la peau favorisant la cicatrisation des plaies
EP2152279A4 (fr) Utilisation d'un tensioactif biologique en tant qu'agent anti-inflammatoire et solution de conservation de tissus
WO2012084164A3 (fr) Composition antimicrobienne présentant des propriétés de soins cutanés
WO2011049327A3 (fr) Composition de soin externe pour la peau comprenant un sel et du sucre en tant que principes actifs pour prévenir et traiter la vaginose et utilisation de cette composition
EP2161023A3 (fr) Agents anti-angiogéniques et procédés d'utilisation
MX2012008890A (es) Composicion de combinacion, que comrpende como ingrediente activo l-carnitina o propionil l-carnitina, para la prevencion o tratamiento de insuficiencia venosa cronica.
WO2011077163A3 (fr) Utilisation
BRPI0921491A2 (pt) uso terapêutico, dietético ou cosmético de compostos com atividade anti-apoptótica específica contra caspase-3, e composições contendo estes compostos
CL2007000850A1 (es) Compuestos derivados de benzimidazol; procedimiento de preparacion; composicion farmaceutica; y uso para prevenir o tratar condiciones de huesos asociadas con la reduccion fuerte o resorcion incrementada de calcio.
EP2050442A4 (fr) Composition pharmaceutique destinée à la prévention et/ou au traitement d'une maladie osseuse, aliment fonctionnel ou aliment diététique contenant la composition, et préparation pharmaceutique contenant la composition en tant que principe actif
WO2011056871A3 (fr) Mécanisme du rhamnolipide
WO2008066775A3 (fr) Compositions et procédés visant à réduire la graisse et à rétracter la peau
EP2801360A3 (fr) Utilisation de nicotine pour le traitement de saignement post-traumatique chez l'homme
WO2010042212A3 (fr) Méthodes de traitement prophylactique ou thérapeutique de la douleur à l'aide de dérivés de spicamycine
WO2009022842A3 (fr) Composition pharmaceutique utile pour prévenir et traiter une maladie liée à la prolifération cellulaire comprenant un mélange de plumes d'oiseau et d'écailles de poisson en tant qu'ingrédient actif
WO2008008468A3 (fr) Compositions et procédés de réduction de la graisse
WO2012051495A3 (fr) Compositions et procédés pour renforcer une réponse biologique à des agents chimiques et des stimuli physiques
WO2010126260A3 (fr) Composition pharmaceutique favorisant la cicatrisation des plaies et contenant de l'acide lysophosphatidique et un inhibiteur de l'adénylyl cyclase en tant que principes actifs

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880101123.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08786013

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010515508

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2008786013

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20107002758

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12668061

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0813925

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20100108